logo
Nearly half of women in Africa will be obese or overweight by 2030

Nearly half of women in Africa will be obese or overweight by 2030

The Guardian06-03-2025
An alarming rise in obesity in Africa has been compared with the HIV epidemic, with stigma and lack of treatment having a disproportionate impact on women.
Almost half of women in Africa will be obese or overweight by the end of the decade, according to a recent study by the World Obesity Federation.
While people in richer countries embrace the use of weight loss jabs to slim, few have any confidence that the groundbreaking medicines will be available in sub-Saharan Africa in the near future.
And treatment for the host of diseases that accompany obesity, including diabetes, heart disease and high blood pressure, can be equally hard to access.
Dr Nomathemba Chandiwana, who specialises in obesity and non-communicable diseases (NCDs), is chief scientific officer at the Desmond Tutu Health Foundation in South Africa.
'Obesity feels like HIV but more compressed,' she said. 'We've got a disease we don't quite understand, it's there, we're not doing much about it. The drugs are kind of there, but not available. Stigma is also an issue. So you can make a lot of parallels.'
In another similarity between the conditions on the African continent, women are more likely than men to be infected with HIV. And while 25% of men in Africa are overweight or obese, for women the figure is 40%. In most other world regions the gap is much smaller, or reversed.
And the trend is accelerating. While 45% of women in Africa will be overweight or obese by 2030, for men the figure is 26%, according to the World Obesity Atlas.
Chandiwana said the question of why obesity was rising faster among women in Africa was complex, and involved multiple intersecting factors.
'Urbanisation and lifestyle shifts play a major role – many African cities lack safe spaces for physical activity, and long working hours, caregiving responsibilities, and safety concerns, etc, make movement harder for women. Unlike men, who may engage in occupational or leisure physical activity, women's daily routines are becoming more sedentary,' she said.
'HIV and antiretroviral therapy (ART) add another layer. In high HIV-burden settings like South Africa, ART-related weight gain, especially with drugs such as dolutegravir, is becoming more noticeable, disproportionately affecting women.'
Biological factors such as reproductive health, menopause, and differences in cravings, metabolism, genetics and hormones are additional factors, she said.
'It is definitely going to get worse as ultra-processed foods become more ubiquitous, climate change increases and [because of] gender inequity,' said Chandiwana, with women facing more barriers to activities such as exercise because of their other commitments. 'We need prevention and treatment targeted specifically at women in South Africa.'
Already, two-thirds of women in South Africa are overweight or obese, the second highest rate on the continent, after Eswatini.
The rates in women could be a warning sign. Research suggests that countries' experiences of rising obesity typically begin with higher levels in women and higher-income groups before spreading through the population.
Chandiwana said she was excited by the possibilities of the new generation of anti-obesity drugs called GLP-1 receptor agonists, such as Wegovy or Mounjaro, which have been popularised in the west by celebrities and politicians such as Oprah Winfrey and Boris Johnson.
She said she had been about to get US funding for the first trial of semaglutide in women with HIV, shortly before the Trump administration froze most research spending.
'I think these drugs are a gamechanger and also they legitimise obesity as a chronic disease,' she said. 'Without treatment, people always look at it as a personal failure. It's you, you haven't done enough. But when you have treatment, we've got more in our toolbox.'
Sign up to Global Dispatch
Get a different world view with a roundup of the best news, features and pictures, curated by our global development team
after newsletter promotion
There is 'an equity issue' she said, where patients' access to the new, 'best-in-class drugs' depend on where they live in the world. She said diabetes patients in South Africa are having to return to using insulin in glass vials, rather than the more modern alternative of pens with measured doses.
'It doesn't matter where you are, there's a drug that's available that can help you with your disease. We do have to try the best we can to give people access,' Chandiwana said.
Johanna Ralston, CEO at the World Obesity Federation, said cultural norms and expectations around obesity in some African countries might play a role in making women more vulnerable to obesity. 'As is the case in many Caribbean and Middle Eastern countries, it is more culturally acceptable for women to have excess weight, and in some cases is desirable.'
Ralston said: 'Gender-responsive action is needed to address these disparities and more research is needed to understand the nuances.'
Brenda Chitindi of the Zambia NCD Alliance agreed that cultural attitudes to obesity were an obstacle to tackling the condition in her country.
'Obesity is a very big challenge in Zambia because we have not taken it seriously. Most of the time we think when you are obese, you eat well – without knowing that it is a disease,' she said.
Speaking at the NCD Alliance Global Forum, a conference for NCD advocates last month, Chitindi said: 'The other big challenge is where the [food] industry right now have brought into the country these fast foods. Where a lot of people have been attracted and, ignoring the regional food we have … they rush to these fast foods to show people 'we are well off, we eat well', without knowing they contribute to obesity.
'The government is looking at the revenue that they get from this industry, which is a very big challenge as well.'
The latest edition of the World Obesity Atlas assessed countries' 'readiness' to address obesity by looking at factors such as their ability to provide treatment for NCDs, and policies for prevention such as taxes on sugary drinks, and restrictions on marketing unhealthy food to children.
These were lacking in many countries, the report's authors found. But they warned that a reduction in the number of adults who are overweight or obese will require 'dramatic policy interventions'.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

British state has a shameful record of moral cowardice
British state has a shameful record of moral cowardice

The Herald Scotland

time13 hours ago

  • The Herald Scotland

British state has a shameful record of moral cowardice

Consider the infected blood scandal, victims of which are only now able to access the Infected Blood Compensation Scheme. From the 1970s to the 1990s, over 30,000 NHS patients were infected with HIV and hepatitis C by infected blood or clotting factor products, killing at least 3,000 people. The history of this scandal is marked by stubbornness and cover-ups from the outset. In the 1970s, American scientists, including Judith Graham Pool, a pioneer in haematology, were characterising the products infecting patients with hepatitis C as 'dangerous' and 'unethical'. The World Health Organization was warning the UK not to import blood from countries with a high prevalence of hepatitis. They were ignored. So too were doctors like Spence Galbraith, the founding director of the Communicable Disease Surveillance Centre in England and Wales, who warned the Government in 1983 that blood products may be transmitting HIV. An NHS pamphlet for blood donors distributed in September 1983 stated that HIV could 'almost certainly' be transmitted by blood products, and the consensus among haemophilia physicians by this point was that blood products were spreading AIDS. Despite that, Ken Clarke, then the Health and Social Care Secretary, made statements to the House of Commons that the evidence was inconclusive and maintained the policy of importing untreated blood products. In the decades since the Government settled out of court, in 1990, with claimants who had been infected with HIV by untreated blood products, inquiries were repeatedly denied and evidence destroyed. In 2000, Caroline Flint revealed to Parliament that papers had been destroyed related to both the HIV litigation and the litigation over hepatitis C infections. In 2009, the Archer Report – a privately-funded investigation into the scandal chaired by Lord Archer, a former Solicitor General – reported that 'some of those who gave evidence to us suspected that there was an exercise in suppressing evidence of negligence or misconduct,' and that one witness, Lord Jenkin, Health Secretary from 1979 to 1981, had been 'left with the clear impression […] that all the files bearing upon the issue of contaminated blood products had been destroyed, and that this had been done 'with intent, in order to draw a line under the disaster.'' Read more by Mark McGeoghegan ​The 2015 Scottish Government-commissioned Penrose Inquiry into the scandal north of the Border was branded a whitewash by victims and campaigners, after it concluded that little could have been done differently, which is untrue, looking at the timeline of warnings, and refused to apportion any blame. Even when a full inquiry was undertaken, it was discovered that hundreds of documents related to the scandal had been removed from archives by Department of Health and Social Care staff and not returned, sparking renewed concerns about a cover-up. As recently as 2023, the Government was still attempting to prevent the implementation of a compensation scheme. The final inquiry report was published last May, concluding that the scandal could have been avoided, that patients were knowingly exposed to 'unacceptable risks', and that the Government and NHS did indeed attempt a cover-up by 'hiding the truth'. It would be easy to say that these scandals are relatively rare, if not for the fact that we've just lived through the culmination of the Horizon IT scandal, in which Post Office officials displayed the same stubbornness and aversion to accountability that the NHS did over infected blood products. This sense of entitlement, to a right to avoid scrutiny and accountability, to a prerogative to avoid paying the price for its screw-ups and those of its staff, manifests in other ways, too. Shamima Begum, stripped of her British citizenship despite having been born and raised in London (Image: BBC/PA Wire) What, for example, is the case of Shamima Begum, stripped of her British citizenship despite having been born and raised in London, if not an attempt by the British state to wash its hands of a teenage girl, groomed online by terrorists, who was ultimately our responsibility as a society and the UK's responsibility as a government? And what of efforts to protect British soldiers from being held accountable for war crimes, committed in Northern Ireland, Iraq, and now Afghanistan? Which brings us back to Afghanistan. We know, for example, that in one instance, a UK Special Forces officer who may have been connected to alleged SAS war crimes personally rejected 1,585 resettlement applications from Afghans who may have witnessed those alleged crimes. When Johnny Mercer, then Veterans Minister, raised his concerns with senior officers, one UK Special Forces officer told him that his concerns were offensive – either 'lying to my face', as Mr Mercer put it, or 'so deeply incompetent that he didn't know.' The super-injunction granted to the Government over the Ministry of Defence data leak of the details of thousands of Afghans is an unprecedented, but logical escalation of the British state's tendency towards avoiding scrutiny of its errors. It prevented MPs from holding the Government accountable for the error or overseeing its spending on the secret relocation scheme for those affected. It meant the victims of that leak had no awareness that their personal information was in the hands of people willing to publish those details online, and potentially to sell them to the Taliban. The argument that the super-injunction was needed to prevent the Taliban finding out about the leak doesn't hold water, given reporting this week showing that it continued long past the point it was clear that the Taliban were aware of it. As journalists affected by the super-injunction, like Lewis Goodall, have argued this week, such a super-injunction should never have been granted and should never be granted again. It undermined Parliamentary democracy to cover up a scandal. However, there's a wider, deeply ingrained set of practices in the British state that need to be examined and, ultimately, abandoned to secure a government that's transparent and accountable to those it governs. Mark McGeoghegan is a Glasgow University researcher of nationalism and contentious politics and an Associate Member of the Centre on Constitutional Change. He can be found on BlueSky @

U.S. program to combat HIV/AIDS survives Trump's latest round of cuts
U.S. program to combat HIV/AIDS survives Trump's latest round of cuts

NBC News

time15 hours ago

  • NBC News

U.S. program to combat HIV/AIDS survives Trump's latest round of cuts

WASHINGTON — PEPFAR, the popular global HIV/AIDS program credited with saving millions of lives, has been spared from a package of billions of dollars in spending cuts that Congress sent to President Donald Trump early Friday morning to sign into law. The original rescissions package Trump requested called for $400 million in cuts to PEPFAR, the President's Emergency Plan for AIDS Relief, which George W. Bush started in 2003. But in the Senate, Democrats and a handful of Republicans objected to the PEPFAR cuts. Appropriations Committee Chairwoman Susan Collins, R-Maine, said the health program had saved an estimated 26 million lives and allowed nearly 8 million babies to be born healthy to mothers living with HIV. "There are some cuts that I can support, but I'm not going to vote to cut global health programs," Collins told reporters last week. Seeking to tamp down the GOP rebellion, the White House this week agreed to make changes to the package, dropping the PEPFAR cuts to secure GOP votes. 'PEPFAR will not be impacted by the rescissions," White House budget director Russell Vought told reporters after he huddled behind closed doors Tuesday with Senate Republicans. Removing those cuts, Vought said, means the package has 'a good chance of passing.' The rescissions package, which would claw back $9 billion in congressionally approved funding for foreign aid and public broadcasting, narrowly passed the Senate early Thursday on a 51-48 vote. Collins was one of two Republicans to vote against the package, lamenting that the White House had not provided details of the cuts and that 'nobody really knows what program reductions are in it.' The House passed the package of cuts early Friday and Trump has vowed to sign it into law. The White House's original rescissions request sent May 28 detailed that the cuts would target only HIV/AIDS programs that "neither provide life-saving treatment nor support American interests." "This rescission proposal aligns with the Administration's efforts to eliminate wasteful foreign assistance programs," the request said. "Enacting the rescission would restore focus on health and life spending. This best serves the American taxpayer." But even some deficit hawks in the House said they supported the decision to preserve PEPFAR funding. "It's very successful. I think it serves a useful purpose," said conservative Rep. Gary Palmer, R-Ala., who voted for the rescissions package. Rep. Tim Burchett, R-Tenn., a member of the Foreign Affairs Committee who also supported the package, said, "It's half the money we've given to Ukraine, and it's saved 25 million lives." Senate Minority Leader Chuck Schumer, D-N.Y., slammed the legislation and said the PEPFAR-related changes were insufficient. 'Cuts to foreign aid will make Americans less safe. It will empower our adversaries,' he said. 'The changes Republicans say they've made to PEPFAR are not enough, and nobody's fooled by small tweaks to this package.' Some advocates were relieved by the removal of PEPFAR cuts but disappointed with the overall package. 'It is always good news when lawmakers prioritize children, especially children who are orphaned or vulnerable to HIV and AIDS. But the larger trend here is not hopeful," said Bruce Lesley, the president of First Focus Campaign for Children. 'While a few senators persuaded their colleagues to preserve funding for these children in this case," he said in a statement, "the Senate's overall decision to hand $9 billion back to the President suggests that what the legislature does actually doesn't matter.'

NHS waiting lists: Working age people a growing proportion of those needing help
NHS waiting lists: Working age people a growing proportion of those needing help

South Wales Guardian

timea day ago

  • South Wales Guardian

NHS waiting lists: Working age people a growing proportion of those needing help

Data tables published for the first time by NHS England also show people in the most deprived parts of the country are more likely to wait more than a year to start hospital treatment than those in the least deprived. The figures, analysed by the PA news agency, show 56.1% of those on the list at the end of June this year were of working age (defined as age 19 to 64), up from 55.8% a year ago and 55.0% in June 2022. At the same time, the proportion of people on the waiting list under the age of 19 has fallen, standing at 10.8% in June this year, down from 11.2% a year earlier and 11.9% in June 2022. The proportion who are over 65 has remained broadly unchanged at around 33.1%. People of working age are also more likely to have to wait more than a year to start treatment (3.0% of patients in this age group at the end of June) than those over 65 (2.5%). However, the proportion is the same as those under 19 (also 3.0%). Meanwhile, people in the most deprived parts of England also face long waits for treatment when compared with those in the wealthiest areas. And for data where sex is recorded, women make up a higher percentage of the waiting list (57%) compared with men (43%). Women are also more likely to be waiting more than 18 and 52 weeks than men. On deprivation, some 3.1% of patients living in the most deprived areas had been waiting more than 12 months to begin treatment at the end of June, compared with 2.7% in the least deprived. The gap is even wider in some regions, with the figures for the Midlands ranging from 3.0% in the most deprived parts to 2.4% in the least deprived; from 2.4% to 1.8% in London; and from 4.9% to 4.0% in eastern England. The data also shows patients in certain ethnic groups are more likely to have to wait more than a year to start hospital treatment than in others. Some 3.2% of patients in England identifying as Bangladeshi had been waiting more than 12 months to begin treatment at the end of June, along with 3.0% of patients of Pakistani and African backgrounds, higher proportions than those identifying as Caribbean (2.9%), Chinese (2.8%), British (2.8%) or Indian (2.7%). Eastern England and south-west England are the regions with the largest ethnicity gap for people waiting more than a year to begin hospital treatment. The Government has announced new neighbourhood health centres in its 10-year plan for the NHS, which will be targeted first at the places where healthy life expectancy is lowest. According to the Department of Health, this includes 'de-industrialised cities and coastal towns, reducing the estimated £240-£330 billion cost of sickness to the economy.' Some 20 'further faster' teams have also been sent in to those NHS trusts with the longest waits to try to bring them down. The new data shows the largest specialty for those on the waiting list aged 18-64 is gynaecology (12% of all 18 to 64-year-olds), while it is ophthalmology for older adults. Health and Social Care Secretary, Wes Streeting, said: 'We inherited an NHS which after years of neglect had left all patients worse off – but some more than others. 'Sunlight is the best disinfectant. Only by being upfront and shining a light on inequalities can we begin to tackle the problem. 'We will give all patients the care they need when they need it as part of our Plan for Change. 'Our 10-Year Health Plan will tackle health inequalities faced across the country, diverting billions of pounds to working-class communities, and providing truly targeted, bespoke care to all patients where they live via the neighbourhood health service.' Stella Vig, NHS national clinical director for elective care, said: 'Understanding patient demographics is vital if we are to identify and tackle the way different groups are treated. 'As well as allowing patients and the public to see the makeup of local lists, NHS teams will be able to analyse the latest data, understand where there is unwarranted variation in waiting times, and work with their communities to take action to reduce it.' Professor Habib Naqvi, chief executive of the NHS Race and Health Observatory, said: 'This is a great step in making ethnic health inequities more visible. 'Without robust, consistent data and transparency about what's happening in the healthcare system, we will not be able to enable genuine equitable decision making in the NHS, nor tackle and eradicate ethnic and racial inequalities in health in a sustained and meaningful way.' It comes as the Government announced that patients with long-term conditions will be automatically referred to specialist charities at the point of diagnosis from next year. Diagnosis Connect will ensure patients are referred directly to charities and support organisations in a move the Government says will 'complement, not replace', NHS care. Siva Anandaciva, director of policy, partnerships and events at The King's Fund, welcomed the new data, but warned the figures show that 'some parts of the country will be left behind' if tackling NHS waiting lists does not become more inclusive. He added: 'The Government's 10-Year Plan for Health does not say enough on how the Government plans to reduce health inequalities – in fact, the last paragraph of the prevention chapter in the plan says that by the end of 10 years this plan will only have begun narrowing health inequalities. 'This is simply not ambitious enough. It is crucial that we see further and faster ambition in the months that come to narrow these avoidable differences in experiences of the NHS.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store